close
close
migores1

Viking Therapeutics stock rose on positive data from the treatment study for the rare metabolic disorder X-ALD

Viking Therapeutics stock rose on positive data from the treatment study for the rare metabolic disorder X-ALD

Viking, which is also developing a diet pill, has a buy rating from all 13 analysts providing coverage.

Related Articles

Back to top button